Medtronic announced earnings per share of $1.5 on revenue of $8.19B. Analysts polled by anticipated EPS of $1.42 on revenue of $8.14B.

Medtronic shares are up 7% from the beginning of the year, still down 4.52% from its 52 week high of $132.25 set on April 29. They are under-performing the S&P 500 which is up 11.71% from the start of the year.

Medtronic’s report follows an earnings beat by Pfizer on May 4, who reported EPS of $0.93 on revenue of $14.58B, compared to forecasts EPS of $0.7759 on revenue of $13.65B.

AbbVie had beat expectations on April 30 with first quarter EPS of $2.95 on revenue of $13.01B, compared to forecast for EPS of $2.81 on revenue of $12.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting’s earnings calendar

Club Trader School

Inscrivez-vous pour recevoir les derniers conseils et stratégies de Trading, ainsi que des cadeaux exclusifs !

Nous promettons de ne jamais vous envoyer de messages indésirables ! Jetez un œil à notre Politique de confidentialité pour plus d’informations.

A lire également